<div id="readability-page-1"><p>Robeco Institutional Asset Management B.V. lifted its position in  Equifax Inc. (NYSE:EFX - Free Report) by 5.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor  owned 69,418 shares of the credit services provider's stock after buying an additional 3,579 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.06% of Equifax worth $17,691,000 as of its most recent SEC filing.</p><ul><li>Why These 3 Large Caps Are Bucking the August Slump</li></ul><p>Other institutional investors have also added to or reduced their stakes in the company. Ashton Thomas Securities LLC acquired a new position in shares of  Equifax during the 3rd quarter worth about $29,000.  Central Pacific Bank Trust Division bought a new position in  Equifax during the fourth quarter worth about $35,000.  Exchange Traded Concepts LLC acquired a new position in  Equifax during the third quarter worth approximately $48,000.  Intact Investment Management Inc. bought a new stake in  Equifax in the third quarter valued at approximately $73,000.  Finally, Pinnacle Financial Partners Inc bought a new position in shares of  Equifax during the 3rd quarter worth approximately $85,000. 96.20% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of research firms recently weighed in on EFX. JPMorgan Chase &amp; Co. dropped their price target on Equifax from $304.00 to $283.00 and set an &#34;overweight&#34; rating on the stock in a research note on Tuesday, November 19th. Wolfe Research cut shares of Equifax from an &#34;outperform&#34; rating to a &#34;peer perform&#34; rating in a research note on Thursday, December 12th. BNP Paribas upgraded shares of Equifax from a &#34;neutral&#34; rating to an &#34;outperform&#34; rating and set a $305.00 price target on the stock in a research note on Monday, December 16th. Needham &amp; Company LLC  restated a &#34;buy&#34; rating and set a $350.00 price objective on shares of Equifax in a research report on Monday, October 28th. Finally, Morgan Stanley decreased their target price on Equifax from $320.00 to $316.00 and set an &#34;overweight&#34; rating on the stock in a research report on Tuesday. Two analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $310.88.</p><ul><li>2 Attractive Large Caps on Sale After Q2 Earnings</li></ul><p><b>Check Out Our Latest Research Report on EFX</b></p><h2>Equifax Price Performance</h2><p>Shares of NYSE:EFX opened at $274.69 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $34.05 billion, a PE ratio of 61.04, a PEG ratio of 2.80 and a beta of 1.57. The firm has a 50 day moving average of $261.24 and a 200-day moving average of $274.87. Equifax Inc. has a 12 month low of $213.02 and a 12 month high of $309.63. </p><h2>Equifax Dividend Announcement</h2><ul><li>Equifax <span>NYSE: EFX<span></span></span> Surges To All Time Highs, But The Best Is Yet To Come</li></ul><p>The firm also recently announced a quarterly dividend, which was paid on Friday, December 13th. Shareholders of record on Friday, November 22nd were paid a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a yield of 0.57%. The ex-dividend date  was Friday, November 22nd. Equifax's payout ratio is presently 34.67%. </p><h2>Insider Buying and Selling at Equifax</h2><p>In other news, EVP Lisa M. Nelson sold 551 shares of the firm's stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $260.39, for a total value of $143,474.89. Following the sale, the executive vice president now directly owns 11,697 shares in the company, valued at approximately $3,045,781.83. This trade represents a 4.50 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own  1.57% of the company's stock. </p><h2>Equifax Profile</h2> (Free Report)<p>Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.</p><h2>Read More</h2><ul><li>Five stocks we like better than Equifax</li><li>How to Start Investing in Real Estate</li><li> Nebius Group: Market Overreaction or Real AI Disruption?</li><li>What Investors Need to Know About Upcoming IPOs</li><li>The Best Way to Invest in Gold Is...</li><li>Most Volatile Stocks, What Investors Need to Know</li><li>Why Nike Stock Could Be 2025’s Top Comeback Play</li></ul><p><strong>Want to see what other hedge funds are holding EFX?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax Inc. (NYSE:EFX - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVGWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVGWA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Equifax Right Now?</h2><p>Before you consider Equifax, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.</p><p>While Equifax currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Robeco Institutional Asset Management B.V. increased its stake in Equifax Inc. (NYSE: EFX) by 5.4% in Q4, owning 69,418 shares valued at approximately $17.69 million. Other institutional investors also acquired new positions in Equifax. Analysts have mixed ratings on the stock, with a consensus target price of $310.88. Equifax recently announced a quarterly dividend of $0.39 per share. The stock opened at $274.69, with a market cap of $34.05 billion and a PE ratio of 61.04.</p>

Robeco Institutional Asset Management B.V. Has $17.69 Million Holdings in Equifax Inc. (NYSE:EFX)